Attached files

file filename
EX-99.1 - EXHIBIT 99.1 - INSMED INCex99_1.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
FORM 8-K

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported):  December 3, 2012

INSMED INCORPORATED
(Exact Name of Registrant as Specified in Its Charter)

Virginia
(State or Other Jurisdiction of Incorporation)

0-30739
54-1972729
(Commission File Number)
(IRS Employer Identification No.)

9 Deer Park Drive, Monmouth Junction, New Jersey
08852
(Address of Principal Executive Offices)
(Zip Code)

(732) 997-4600
(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

£      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

£      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

£     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

£     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


 
 

 

Item 7.01
Regulation FD Disclosure.
 
In December 2012, Insmed Incorporated updated the Company’s Investor Presentation. Our Chief Executive Officer and President, Will Lewis will present some or all of the December 2012 Investor Presentation to various conferences and investors in the coming months. A copy of the presentation materials is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.
 
Item 9.01
Financial Statements and Exhibits.

(d)           Exhibits

Exhibit No.
 
Description
     
 
December 2012 Investor Presentation

 
 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
Insmed Incorporated
     
Date: December 3, 2012
   
     
 
By:
/s/ Andrew Drechsler
 
Name:
Andrew Drechsler
 
Title:
Chief Financial Officer